Department of Plastic Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan.
Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan.
J Reconstr Microsurg. 2021 Jul;37(6):541-550. doi: 10.1055/s-0040-1722759. Epub 2021 Jan 31.
Intraoperative vasospasm during reconstructive microvascular surgery is often unpredictable and may lead to devastating flap loss. Therefore, various vasodilators are used in reconstructive microsurgery to prevent and relieve vasospasm. Lidocaine is a vasodilator commonly used in microvascular surgery. Although many reports have described its in vitro and in vivo concentration-dependent vasodilatory effects, limited studies have examined the pharmacological effects of lidocaine on blood vessels in terms of persistence and titer.
In this study, the vasodilatory effect of lidocaine was examined by using the wire myograph system. Abdominal aortas were harvested from female rats, sliced into rings of 1-mm thickness, and mounted in the wire myograph system. Next, 10, 5, 2, and 1% lidocaine solutions were applied to the artery, and the change in vasodilation force, persistence of the force, and time required to reach equilibrium were measured.
The vasodilatory effect was confirmed in all groups following lidocaine treatment. Although strong vasodilation was observed in the 10% lidocaine group, it was accompanied by irreversible degeneration of the artery. Vasodilation in the 1% lidocaine group was weaker than that in the other groups 500 seconds after lidocaine addition ( < 0.05). Between the 5 and 2% lidocaine groups, 5% lidocaine showed a stronger vasodilatory effect 400 to 600 seconds after lidocaine addition ( < 0.01); however, there was no significant difference in these groups after 700 seconds. Additionally, there was no difference in the time required for the relaxation force to reach equilibrium among the 5, 2, and 1% lidocaine groups.
Although our study confirmed the dose-dependent vasodilatory effect of lidocaine, 5% lidocaine showed the best vasodilatory effect and continuity with minimal irreversible changes in the arterial tissue.
在重建性微血管手术中,术中血管痉挛往往是不可预测的,可能导致灾难性的皮瓣丢失。因此,在重建性显微外科中使用各种血管扩张剂来预防和缓解血管痉挛。利多卡因是一种常用于显微血管手术的血管扩张剂。尽管许多报道描述了其体外和体内浓度依赖性的血管扩张作用,但有限的研究检查了利多卡因对血管的药理学作用,特别是在持久性和效价方面。
本研究采用wire myograph 系统来检查利多卡因的血管扩张作用。从雌性大鼠中取出腹主动脉,切成 1 毫米厚的环,并安装在 wire myograph 系统中。然后,将 10%、5%、2%和 1%的利多卡因溶液应用于动脉,测量血管扩张力的变化、力的持久性以及达到平衡所需的时间。
所有组在利多卡因处理后均证实有血管扩张作用。虽然 10%利多卡因组观察到强烈的血管扩张,但伴随着动脉的不可逆转退化。与其他组相比,在加入利多卡因后 500 秒时,1%利多卡因组的血管扩张较弱(<0.05)。在 5%和 2%利多卡因组之间,在加入利多卡因后 400 至 600 秒时,5%利多卡因显示出更强的血管扩张作用(<0.01);然而,在 700 秒后,这些组之间没有显著差异。此外,5%、2%和 1%利多卡因组的松弛力达到平衡所需的时间没有差异。
虽然我们的研究证实了利多卡因的剂量依赖性血管扩张作用,但 5%利多卡因显示出最佳的血管扩张作用和连续性,动脉组织的不可逆变化最小。